The biologic hernia repair mesh market size has grown strongly in recent years. It will grow from $1.85 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing incidence of hernia disorders, limitations of synthetic mesh in infected cases, growing surgical procedure volumes, rising hospital-based hernia repairs, early adoption of tissue-based implants.
The biologic hernia repair mesh market size is expected to see strong growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to advancements in biologic tissue processing technologies, growing demand for patient-specific repair solutions, rising awareness of post-surgical complications, expansion of ambulatory surgical centers, increasing surgeon preference for regenerative materials. Major trends in the forecast period include rising preference for biologic mesh in high-risk hernia repairs, increasing adoption of absorbable and regenerative mesh solutions, growing use in complex and contaminated surgical cases, expansion of minimally invasive and laparoscopic hernia procedures, higher clinical focus on reduced infection and recurrence rates.
The rising number of hernia cases is anticipated to drive the expansion of the biologic hernia repair mesh market in the coming years. Hernia cases denote instances where an internal organ or tissue abnormally protrudes through a weakened area in the muscle or connective tissue. The increase in hernia cases is linked to growing obesity rates, as excess body weight places additional pressure on abdominal muscles, thereby heightening the risk of hernia development. Biologic hernia repair mesh helps in managing hernia cases by providing a scaffold made of natural tissue that supports healing, integrates with the patient’s body, and reduces the chances of rejection or chronic inflammation. For example, in November 2024, the British Hernia Society, a UK-based professional organization representing hernia surgeons in the United Kingdom and Ireland, reported that its newly launched British Hernia Society Registry had registrations from over 100 surgeons at its inaugural conference. By January 2025, the registry had recorded 400 cases contributed by 30 surgeons across 31 hospitals, demonstrating rapid early adoption and underscoring the ongoing clinical burden of hernia cases. Consequently, the rising prevalence of hernia cases is fueling the growth of the biologic hernia repair mesh market.
Leading companies in the biologic hernia repair mesh market are focusing on the development of innovative solutions, such as reinforced biologic mesh, to improve strength, flexibility, and tissue integration. Reinforced biologic mesh combines biologic tissue with synthetic fibers to enhance durability, support tissue regeneration, and minimize the risk of hernia recurrence. For example, in April 2024, TELA Bio Inc. introduced OviTex inguinal hernia repair (IHR), a reinforced biologic mesh designed for inguinal hernia repair. This mesh is specifically intended for laparoscopic and robotic procedures and uses a combination of biologic ovine extracellular matrix (ECM) and minimal synthetic polymer to deliver strength, support rapid tissue integration, and reduce the risk of complications. It offers advantages such as lower recurrence rates, faster healing, and higher patient satisfaction, addressing the limitations of traditional synthetic meshes.
In February 2024, RTI Surgical Inc., a US-based contract development and manufacturing organization (CDMO), acquired Cook Biotech Inc. for an undisclosed sum. This acquisition allows RTI Surgical to position itself as the only regenerative medicine CDMO capable of providing both allograft and xenograft biomaterials at scale, strengthening its leadership in soft tissue and expanding its market footprint. Cook Biotech Inc. is a US-based company specializing in regenerative medicine, manufactures biologic hernia repair mesh.
Major companies operating in the biologic hernia repair mesh market are Johnson And Johnson, Medtronic plc, DSM Biomedical, W L Gore And Associates Inc, Meril Life Sciences, Cook Medical LLC, Integra LifeSciences Corporation, MTF Biologics, LifeCell Corporation, AlloSource, TELA Bio Inc, Kerecis, Assut Europe S p A, Serag Wiessner GmbH And Co KG, Aroa Biosurgery Limited, ACell Inc, Tissue Regenix Group plc, RTI Surgical Inc, Beijing Datsing Bio Tech Co Ltd, Shanghai Pine And Power Biotech Co Ltd, Axogen Inc, XenoSure Biologics.
North America was the largest region in the biologic hernia repair mesh market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic hernia repair mesh market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biologic hernia repair mesh market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biologic hernia repair mesh market by increasing costs associated with importing processed biologic tissues and advanced manufacturing equipment. Product types such as porcine and bovine-derived meshes are particularly impacted, with North America and Asia-Pacific regions experiencing pricing pressures due to cross-border trade dependencies. These cost increases can slow adoption in price-sensitive healthcare systems. However, tariffs have also encouraged regional sourcing, local tissue processing, and investments in domestic manufacturing capabilities, supporting long-term supply chain stability.
The biologic hernia repair mesh market research report is one of a series of new reports that provides biologic hernia repair mesh market statistics, including biologic hernia repair mesh industry global market size, regional shares, competitors with a biologic hernia repair mesh market share, detailed biologic hernia repair mesh market segments, market trends and opportunities, and any further data you may need to thrive in the biologic hernia repair mesh industry. This biologic hernia repair mesh market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biologic hernia repair mesh is an implant made from processed human or animal tissues, used to strengthen and support weakened areas during hernia repair surgeries. The mesh is gradually absorbed by the body, encouraging natural tissue regeneration, which makes it particularly suitable for patients at higher risk of infection or those undergoing complex repairs.
The primary types of biologic hernia repair mesh include partially absorbable and fully absorbable meshes. Partially absorbable meshes are composed of both absorbable and non-absorbable materials. Common variants include porcine, bovine, and human dermis meshes, among others. These meshes are distributed through various channels such as direct sales, distributors, online platforms, and pharmacies. They are used in procedures like inguinal, ventral, and umbilical hernia repairs. Key end users include hospitals, ambulatory surgical centers, clinics, and other healthcare facilities.
The biologic hernia repair mesh market consists of sales of Strattice reconstructive tissue matrix, Surgimend, and Ovitex. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biologic hernia repair mesh market size is expected to see strong growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to advancements in biologic tissue processing technologies, growing demand for patient-specific repair solutions, rising awareness of post-surgical complications, expansion of ambulatory surgical centers, increasing surgeon preference for regenerative materials. Major trends in the forecast period include rising preference for biologic mesh in high-risk hernia repairs, increasing adoption of absorbable and regenerative mesh solutions, growing use in complex and contaminated surgical cases, expansion of minimally invasive and laparoscopic hernia procedures, higher clinical focus on reduced infection and recurrence rates.
The rising number of hernia cases is anticipated to drive the expansion of the biologic hernia repair mesh market in the coming years. Hernia cases denote instances where an internal organ or tissue abnormally protrudes through a weakened area in the muscle or connective tissue. The increase in hernia cases is linked to growing obesity rates, as excess body weight places additional pressure on abdominal muscles, thereby heightening the risk of hernia development. Biologic hernia repair mesh helps in managing hernia cases by providing a scaffold made of natural tissue that supports healing, integrates with the patient’s body, and reduces the chances of rejection or chronic inflammation. For example, in November 2024, the British Hernia Society, a UK-based professional organization representing hernia surgeons in the United Kingdom and Ireland, reported that its newly launched British Hernia Society Registry had registrations from over 100 surgeons at its inaugural conference. By January 2025, the registry had recorded 400 cases contributed by 30 surgeons across 31 hospitals, demonstrating rapid early adoption and underscoring the ongoing clinical burden of hernia cases. Consequently, the rising prevalence of hernia cases is fueling the growth of the biologic hernia repair mesh market.
Leading companies in the biologic hernia repair mesh market are focusing on the development of innovative solutions, such as reinforced biologic mesh, to improve strength, flexibility, and tissue integration. Reinforced biologic mesh combines biologic tissue with synthetic fibers to enhance durability, support tissue regeneration, and minimize the risk of hernia recurrence. For example, in April 2024, TELA Bio Inc. introduced OviTex inguinal hernia repair (IHR), a reinforced biologic mesh designed for inguinal hernia repair. This mesh is specifically intended for laparoscopic and robotic procedures and uses a combination of biologic ovine extracellular matrix (ECM) and minimal synthetic polymer to deliver strength, support rapid tissue integration, and reduce the risk of complications. It offers advantages such as lower recurrence rates, faster healing, and higher patient satisfaction, addressing the limitations of traditional synthetic meshes.
In February 2024, RTI Surgical Inc., a US-based contract development and manufacturing organization (CDMO), acquired Cook Biotech Inc. for an undisclosed sum. This acquisition allows RTI Surgical to position itself as the only regenerative medicine CDMO capable of providing both allograft and xenograft biomaterials at scale, strengthening its leadership in soft tissue and expanding its market footprint. Cook Biotech Inc. is a US-based company specializing in regenerative medicine, manufactures biologic hernia repair mesh.
Major companies operating in the biologic hernia repair mesh market are Johnson And Johnson, Medtronic plc, DSM Biomedical, W L Gore And Associates Inc, Meril Life Sciences, Cook Medical LLC, Integra LifeSciences Corporation, MTF Biologics, LifeCell Corporation, AlloSource, TELA Bio Inc, Kerecis, Assut Europe S p A, Serag Wiessner GmbH And Co KG, Aroa Biosurgery Limited, ACell Inc, Tissue Regenix Group plc, RTI Surgical Inc, Beijing Datsing Bio Tech Co Ltd, Shanghai Pine And Power Biotech Co Ltd, Axogen Inc, XenoSure Biologics.
North America was the largest region in the biologic hernia repair mesh market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic hernia repair mesh market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biologic hernia repair mesh market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biologic hernia repair mesh market by increasing costs associated with importing processed biologic tissues and advanced manufacturing equipment. Product types such as porcine and bovine-derived meshes are particularly impacted, with North America and Asia-Pacific regions experiencing pricing pressures due to cross-border trade dependencies. These cost increases can slow adoption in price-sensitive healthcare systems. However, tariffs have also encouraged regional sourcing, local tissue processing, and investments in domestic manufacturing capabilities, supporting long-term supply chain stability.
The biologic hernia repair mesh market research report is one of a series of new reports that provides biologic hernia repair mesh market statistics, including biologic hernia repair mesh industry global market size, regional shares, competitors with a biologic hernia repair mesh market share, detailed biologic hernia repair mesh market segments, market trends and opportunities, and any further data you may need to thrive in the biologic hernia repair mesh industry. This biologic hernia repair mesh market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biologic hernia repair mesh is an implant made from processed human or animal tissues, used to strengthen and support weakened areas during hernia repair surgeries. The mesh is gradually absorbed by the body, encouraging natural tissue regeneration, which makes it particularly suitable for patients at higher risk of infection or those undergoing complex repairs.
The primary types of biologic hernia repair mesh include partially absorbable and fully absorbable meshes. Partially absorbable meshes are composed of both absorbable and non-absorbable materials. Common variants include porcine, bovine, and human dermis meshes, among others. These meshes are distributed through various channels such as direct sales, distributors, online platforms, and pharmacies. They are used in procedures like inguinal, ventral, and umbilical hernia repairs. Key end users include hospitals, ambulatory surgical centers, clinics, and other healthcare facilities.
The biologic hernia repair mesh market consists of sales of Strattice reconstructive tissue matrix, Surgimend, and Ovitex. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biologic Hernia Repair Mesh Market Characteristics
3. Biologic Hernia Repair Mesh Market Supply Chain Analysis
4. Global Biologic Hernia Repair Mesh Market Trends and Strategies
5. Biologic Hernia Repair Mesh Market Analysis of End Use Industries
7. Global Biologic Hernia Repair Mesh Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biologic Hernia Repair Mesh Total Addressable Market (TAM) Analysis for the Market
9. Biologic Hernia Repair Mesh Market Segmentation
10. Biologic Hernia Repair Mesh Market Regional and Country Analysis
11. Asia-Pacific Biologic Hernia Repair Mesh Market
12. China Biologic Hernia Repair Mesh Market
13. India Biologic Hernia Repair Mesh Market
14. Japan Biologic Hernia Repair Mesh Market
15. Australia Biologic Hernia Repair Mesh Market
16. Indonesia Biologic Hernia Repair Mesh Market
17. South Korea Biologic Hernia Repair Mesh Market
18. Taiwan Biologic Hernia Repair Mesh Market
19. South East Asia Biologic Hernia Repair Mesh Market
20. Western Europe Biologic Hernia Repair Mesh Market
21. UK Biologic Hernia Repair Mesh Market
22. Germany Biologic Hernia Repair Mesh Market
23. France Biologic Hernia Repair Mesh Market
24. Italy Biologic Hernia Repair Mesh Market
25. Spain Biologic Hernia Repair Mesh Market
26. Eastern Europe Biologic Hernia Repair Mesh Market
27. Russia Biologic Hernia Repair Mesh Market
28. North America Biologic Hernia Repair Mesh Market
29. USA Biologic Hernia Repair Mesh Market
30. Canada Biologic Hernia Repair Mesh Market
31. South America Biologic Hernia Repair Mesh Market
32. Brazil Biologic Hernia Repair Mesh Market
33. Middle East Biologic Hernia Repair Mesh Market
34. Africa Biologic Hernia Repair Mesh Market
36. Biologic Hernia Repair Mesh Market Competitive Landscape and Company Profiles
37. Biologic Hernia Repair Mesh Market Other Major and Innovative Companies
40. Biologic Hernia Repair Mesh Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Biologic Hernia Repair Mesh Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biologic hernia repair mesh market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biologic hernia repair mesh? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biologic hernia repair mesh market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Absorption: Partially Absorbable Hernia Repair Mesh; Fully Absorbable Hernia Repair Mesh2) By Product Type: Porcine; Bovine; Human Dermis; Other Product Types
3) By Distribution Channel: Direct Sales; Distributors; Online Sales; Pharmacies
4) By Application: Inguinal Hernia Repair; Ventral Hernia Repair; Umbilical Hernia Repair; Other Hernia Repairs
5) By End-User: Hospitals; Ambulatory Surgical Centers; Clinics; Other End Users
Subsegments:
1) By Partially Absorbable Hernia Repair Mesh: Composite Mesh; Reinforced Biologic Mesh2) By Fully Absorbable Hernia Repair Mesh: Extracellular Matrix (ECM) Mesh; Acellular Dermal Matrix (ADM) Mesh
Companies Mentioned: Johnson And Johnson; Medtronic plc; DSM Biomedical; W L Gore And Associates Inc; Meril Life Sciences; Cook Medical LLC; Integra LifeSciences Corporation; MTF Biologics; LifeCell Corporation; AlloSource; TELA Bio Inc; Kerecis; Assut Europe S p A; Serag Wiessner GmbH And Co KG; Aroa Biosurgery Limited; ACell Inc; Tissue Regenix Group plc; RTI Surgical Inc; Beijing Datsing Bio Tech Co Ltd; Shanghai Pine And Power Biotech Co Ltd; Axogen Inc; XenoSure Biologics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biologic Hernia Repair Mesh market report include:- Johnson And Johnson
- Medtronic plc
- DSM Biomedical
- W L Gore And Associates Inc
- Meril Life Sciences
- Cook Medical LLC
- Integra LifeSciences Corporation
- MTF Biologics
- LifeCell Corporation
- AlloSource
- TELA Bio Inc
- Kerecis
- Assut Europe S p A
- Serag Wiessner GmbH And Co KG
- Aroa Biosurgery Limited
- ACell Inc
- Tissue Regenix Group plc
- RTI Surgical Inc
- Beijing Datsing Bio Tech Co Ltd
- Shanghai Pine And Power Biotech Co Ltd
- Axogen Inc
- XenoSure Biologics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.99 Billion |
| Forecasted Market Value ( USD | $ 2.63 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
